nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—MPO—Calcipotriol—psoriasis	0.282	0.421	CbGbCtD
Melatonin—CYP1A1—Clobetasol propionate—psoriasis	0.0822	0.123	CbGbCtD
Melatonin—CYP1A1—Methoxsalen—psoriasis	0.0432	0.0644	CbGbCtD
Melatonin—CYP19A1—Betamethasone—psoriasis	0.0393	0.0587	CbGbCtD
Melatonin—CYP1A2—Clobetasol propionate—psoriasis	0.0367	0.0548	CbGbCtD
Melatonin—CYP1A1—Cholecalciferol—psoriasis	0.0286	0.0427	CbGbCtD
Melatonin—CYP1B1—Dexamethasone—psoriasis	0.0282	0.0421	CbGbCtD
Melatonin—CYP19A1—Dexamethasone—psoriasis	0.0229	0.0341	CbGbCtD
Melatonin—CYP1A2—Methoxsalen—psoriasis	0.0193	0.0288	CbGbCtD
Melatonin—CYP2C19—Cholecalciferol—psoriasis	0.0139	0.0207	CbGbCtD
Melatonin—SLC22A8—Methotrexate—psoriasis	0.0125	0.0187	CbGbCtD
Melatonin—CYP1A1—Dexamethasone—psoriasis	0.0124	0.0185	CbGbCtD
Melatonin—CYP2C9—Cholecalciferol—psoriasis	0.0115	0.0172	CbGbCtD
Melatonin—CYP2C19—Prednisone—psoriasis	0.0096	0.0143	CbGbCtD
Melatonin—CYP2C19—Cyclosporine—psoriasis	0.0091	0.0136	CbGbCtD
Melatonin—CYP2C9—Cyclosporine—psoriasis	0.00757	0.0113	CbGbCtD
Melatonin—CYP2C19—Dexamethasone—psoriasis	0.006	0.00894	CbGbCtD
Melatonin—CYP2C9—Dexamethasone—psoriasis	0.00498	0.00744	CbGbCtD
Melatonin—CALR—skin epidermis—psoriasis	0.0039	0.287	CbGeAlD
Melatonin—MPO—endothelium—psoriasis	0.00123	0.0904	CbGeAlD
Melatonin—CALR—skin of body—psoriasis	0.00121	0.0889	CbGeAlD
Melatonin—CALR—tendon—psoriasis	0.00092	0.0677	CbGeAlD
Melatonin—CYP1A1—skin epidermis—psoriasis	0.000915	0.0673	CbGeAlD
Melatonin—CALM2—endothelium—psoriasis	0.000868	0.0638	CbGeAlD
Melatonin—CALM1—endothelium—psoriasis	0.000864	0.0635	CbGeAlD
Melatonin—MPO—skin of body—psoriasis	0.000525	0.0386	CbGeAlD
Melatonin—NQO2—tendon—psoriasis	0.000519	0.0382	CbGeAlD
Melatonin—CYP1B1—skin of body—psoriasis	0.000401	0.0295	CbGeAlD
Melatonin—CALM2—skin of body—psoriasis	0.00037	0.0272	CbGeAlD
Melatonin—CALM1—skin of body—psoriasis	0.000369	0.0271	CbGeAlD
Melatonin—CALM3—tendon—psoriasis	0.000359	0.0264	CbGeAlD
Melatonin—CYP1B1—tendon—psoriasis	0.000305	0.0224	CbGeAlD
Melatonin—CYP1A1—skin of body—psoriasis	0.000283	0.0208	CbGeAlD
Melatonin—CALM2—tendon—psoriasis	0.000282	0.0207	CbGeAlD
Melatonin—CALM1—tendon—psoriasis	0.000281	0.0206	CbGeAlD
Melatonin—Loss of consciousness—Hydrocortisone—psoriasis	0.000129	0.000667	CcSEcCtD
Melatonin—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000129	0.000667	CcSEcCtD
Melatonin—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000129	0.000666	CcSEcCtD
Melatonin—Skin disorder—Mycophenolate mofetil—psoriasis	0.000128	0.00066	CcSEcCtD
Melatonin—Hypertension—Hydrocortisone—psoriasis	0.000127	0.000655	CcSEcCtD
Melatonin—Vomiting—Hydroxyurea—psoriasis	0.000126	0.000654	CcSEcCtD
Melatonin—Angioedema—Triamcinolone—psoriasis	0.000126	0.000653	CcSEcCtD
Melatonin—Abdominal discomfort—Methotrexate—psoriasis	0.000125	0.000649	CcSEcCtD
Melatonin—Rash—Hydroxyurea—psoriasis	0.000125	0.000648	CcSEcCtD
Melatonin—Erythema—Betamethasone—psoriasis	0.000125	0.000648	CcSEcCtD
Melatonin—Erythema—Dexamethasone—psoriasis	0.000125	0.000648	CcSEcCtD
Melatonin—Dermatitis—Hydroxyurea—psoriasis	0.000125	0.000648	CcSEcCtD
Melatonin—Headache—Hydroxyurea—psoriasis	0.000125	0.000644	CcSEcCtD
Melatonin—Anxiety—Hydrocortisone—psoriasis	0.000124	0.000644	CcSEcCtD
Melatonin—Vertigo—Triamcinolone—psoriasis	0.000124	0.000642	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000124	0.000642	CcSEcCtD
Melatonin—Syncope—Triamcinolone—psoriasis	0.000124	0.000641	CcSEcCtD
Melatonin—Connective tissue disorder—Prednisone—psoriasis	0.000123	0.000637	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000123	0.000635	CcSEcCtD
Melatonin—Insomnia—Cyclosporine—psoriasis	0.000122	0.00063	CcSEcCtD
Melatonin—Loss of consciousness—Triamcinolone—psoriasis	0.000121	0.000628	CcSEcCtD
Melatonin—Paraesthesia—Cyclosporine—psoriasis	0.000121	0.000626	CcSEcCtD
Melatonin—Shock—Prednisolone—psoriasis	0.000121	0.000624	CcSEcCtD
Melatonin—Somnolence—Cyclosporine—psoriasis	0.00012	0.00062	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.00012	0.000619	CcSEcCtD
Melatonin—Asthenia—Mycophenolic acid—psoriasis	0.000119	0.000618	CcSEcCtD
Melatonin—Hypertension—Triamcinolone—psoriasis	0.000119	0.000617	CcSEcCtD
Melatonin—Infection—Hydrocortisone—psoriasis	0.000119	0.000615	CcSEcCtD
Melatonin—Insomnia—Mycophenolate mofetil—psoriasis	0.000119	0.000615	CcSEcCtD
Melatonin—Dyspepsia—Cyclosporine—psoriasis	0.000119	0.000613	CcSEcCtD
Melatonin—Nausea—Hydroxyurea—psoriasis	0.000118	0.000611	CcSEcCtD
Melatonin—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000118	0.00061	CcSEcCtD
Melatonin—Pruritus—Mycophenolic acid—psoriasis	0.000118	0.000609	CcSEcCtD
Melatonin—Shock—Hydrocortisone—psoriasis	0.000118	0.000609	CcSEcCtD
Melatonin—Nervous system disorder—Hydrocortisone—psoriasis	0.000117	0.000607	CcSEcCtD
Melatonin—Eye disorder—Prednisone—psoriasis	0.000117	0.000606	CcSEcCtD
Melatonin—Somnolence—Mycophenolate mofetil—psoriasis	0.000117	0.000604	CcSEcCtD
Melatonin—Infestation NOS—Methotrexate—psoriasis	0.000117	0.000604	CcSEcCtD
Melatonin—Infestation—Methotrexate—psoriasis	0.000117	0.000604	CcSEcCtD
Melatonin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000116	0.000602	CcSEcCtD
Melatonin—Skin disorder—Hydrocortisone—psoriasis	0.000116	0.000602	CcSEcCtD
Melatonin—Fatigue—Cyclosporine—psoriasis	0.000116	0.000601	CcSEcCtD
Melatonin—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000116	0.000598	CcSEcCtD
Melatonin—Pain—Cyclosporine—psoriasis	0.000115	0.000596	CcSEcCtD
Melatonin—Dry mouth—Triamcinolone—psoriasis	0.000115	0.000595	CcSEcCtD
Melatonin—Angioedema—Betamethasone—psoriasis	0.000115	0.000592	CcSEcCtD
Melatonin—Angioedema—Dexamethasone—psoriasis	0.000115	0.000592	CcSEcCtD
Melatonin—Stomatitis—Methotrexate—psoriasis	0.000114	0.000589	CcSEcCtD
Melatonin—Angiopathy—Prednisone—psoriasis	0.000114	0.000588	CcSEcCtD
Melatonin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000113	0.000587	CcSEcCtD
Melatonin—Immune system disorder—Prednisone—psoriasis	0.000113	0.000586	CcSEcCtD
Melatonin—Vertigo—Betamethasone—psoriasis	0.000113	0.000582	CcSEcCtD
Melatonin—Vertigo—Dexamethasone—psoriasis	0.000113	0.000582	CcSEcCtD
Melatonin—Syncope—Dexamethasone—psoriasis	0.000112	0.000581	CcSEcCtD
Melatonin—Syncope—Betamethasone—psoriasis	0.000112	0.000581	CcSEcCtD
Melatonin—Pain—Mycophenolate mofetil—psoriasis	0.000112	0.000581	CcSEcCtD
Melatonin—Infection—Triamcinolone—psoriasis	0.000112	0.000579	CcSEcCtD
Melatonin—Haematuria—Methotrexate—psoriasis	0.000111	0.000576	CcSEcCtD
Melatonin—Shock—Triamcinolone—psoriasis	0.000111	0.000574	CcSEcCtD
Melatonin—Insomnia—Prednisolone—psoriasis	0.000111	0.000574	CcSEcCtD
Melatonin—Hepatobiliary disease—Methotrexate—psoriasis	0.00011	0.000571	CcSEcCtD
Melatonin—Gastrointestinal pain—Cyclosporine—psoriasis	0.00011	0.00057	CcSEcCtD
Melatonin—Loss of consciousness—Dexamethasone—psoriasis	0.00011	0.00057	CcSEcCtD
Melatonin—Loss of consciousness—Betamethasone—psoriasis	0.00011	0.00057	CcSEcCtD
Melatonin—Dizziness—Mycophenolic acid—psoriasis	0.00011	0.00057	CcSEcCtD
Melatonin—Paraesthesia—Prednisolone—psoriasis	0.00011	0.000569	CcSEcCtD
Melatonin—Mental disorder—Prednisone—psoriasis	0.00011	0.000568	CcSEcCtD
Melatonin—Malnutrition—Prednisone—psoriasis	0.000109	0.000565	CcSEcCtD
Melatonin—Erythema—Prednisone—psoriasis	0.000109	0.000565	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000109	0.000564	CcSEcCtD
Melatonin—Insomnia—Hydrocortisone—psoriasis	0.000108	0.00056	CcSEcCtD
Melatonin—Hypertension—Betamethasone—psoriasis	0.000108	0.00056	CcSEcCtD
Melatonin—Hypertension—Dexamethasone—psoriasis	0.000108	0.00056	CcSEcCtD
Melatonin—Paraesthesia—Hydrocortisone—psoriasis	0.000107	0.000556	CcSEcCtD
Melatonin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000107	0.000556	CcSEcCtD
Melatonin—Abdominal pain—Cyclosporine—psoriasis	0.000106	0.000551	CcSEcCtD
Melatonin—Anxiety—Dexamethasone—psoriasis	0.000106	0.00055	CcSEcCtD
Melatonin—Anxiety—Betamethasone—psoriasis	0.000106	0.00055	CcSEcCtD
Melatonin—Vomiting—Mycophenolic acid—psoriasis	0.000106	0.000548	CcSEcCtD
Melatonin—Dyspepsia—Hydrocortisone—psoriasis	0.000105	0.000545	CcSEcCtD
Melatonin—Rash—Mycophenolic acid—psoriasis	0.000105	0.000543	CcSEcCtD
Melatonin—Dermatitis—Mycophenolic acid—psoriasis	0.000105	0.000543	CcSEcCtD
Melatonin—Pain—Prednisolone—psoriasis	0.000105	0.000542	CcSEcCtD
Melatonin—Headache—Mycophenolic acid—psoriasis	0.000104	0.00054	CcSEcCtD
Melatonin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000104	0.000537	CcSEcCtD
Melatonin—Urinary tract disorder—Methotrexate—psoriasis	0.000103	0.000535	CcSEcCtD
Melatonin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000103	0.000535	CcSEcCtD
Melatonin—Fatigue—Hydrocortisone—psoriasis	0.000103	0.000534	CcSEcCtD
Melatonin—Vision blurred—Prednisone—psoriasis	0.000103	0.000532	CcSEcCtD
Melatonin—Urethral disorder—Methotrexate—psoriasis	0.000103	0.000531	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000103	0.000531	CcSEcCtD
Melatonin—Pain—Hydrocortisone—psoriasis	0.000102	0.00053	CcSEcCtD
Melatonin—Insomnia—Triamcinolone—psoriasis	0.000102	0.000527	CcSEcCtD
Melatonin—Infection—Betamethasone—psoriasis	0.000102	0.000526	CcSEcCtD
Melatonin—Infection—Dexamethasone—psoriasis	0.000102	0.000526	CcSEcCtD
Melatonin—Paraesthesia—Triamcinolone—psoriasis	0.000101	0.000524	CcSEcCtD
Melatonin—Shock—Dexamethasone—psoriasis	0.000101	0.000521	CcSEcCtD
Melatonin—Shock—Betamethasone—psoriasis	0.000101	0.000521	CcSEcCtD
Melatonin—Nervous system disorder—Dexamethasone—psoriasis	0.0001	0.000519	CcSEcCtD
Melatonin—Nervous system disorder—Betamethasone—psoriasis	0.0001	0.000519	CcSEcCtD
Melatonin—Agitation—Prednisone—psoriasis	0.0001	0.000519	CcSEcCtD
Melatonin—Thrombocytopenia—Dexamethasone—psoriasis	0.0001	0.000518	CcSEcCtD
Melatonin—Thrombocytopenia—Betamethasone—psoriasis	0.0001	0.000518	CcSEcCtD
Melatonin—Angioedema—Prednisone—psoriasis	9.97e-05	0.000516	CcSEcCtD
Melatonin—Hypersensitivity—Cyclosporine—psoriasis	9.92e-05	0.000513	CcSEcCtD
Melatonin—Dyspepsia—Triamcinolone—psoriasis	9.92e-05	0.000513	CcSEcCtD
Melatonin—Nausea—Mycophenolic acid—psoriasis	9.89e-05	0.000512	CcSEcCtD
Melatonin—Vertigo—Prednisone—psoriasis	9.8e-05	0.000507	CcSEcCtD
Melatonin—Eye disorder—Methotrexate—psoriasis	9.79e-05	0.000507	CcSEcCtD
Melatonin—Gastrointestinal pain—Hydrocortisone—psoriasis	9.79e-05	0.000506	CcSEcCtD
Melatonin—Syncope—Prednisone—psoriasis	9.79e-05	0.000506	CcSEcCtD
Melatonin—Cardiac disorder—Methotrexate—psoriasis	9.72e-05	0.000503	CcSEcCtD
Melatonin—Fatigue—Triamcinolone—psoriasis	9.72e-05	0.000503	CcSEcCtD
Melatonin—Hypersensitivity—Mycophenolate mofetil—psoriasis	9.68e-05	0.000501	CcSEcCtD
Melatonin—Asthenia—Cyclosporine—psoriasis	9.66e-05	0.0005	CcSEcCtD
Melatonin—Pain—Triamcinolone—psoriasis	9.64e-05	0.000499	CcSEcCtD
Melatonin—Loss of consciousness—Prednisone—psoriasis	9.59e-05	0.000496	CcSEcCtD
Melatonin—Pruritus—Cyclosporine—psoriasis	9.53e-05	0.000493	CcSEcCtD
Melatonin—Angiopathy—Methotrexate—psoriasis	9.51e-05	0.000492	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—psoriasis	9.46e-05	0.00049	CcSEcCtD
Melatonin—Abdominal pain—Hydrocortisone—psoriasis	9.46e-05	0.00049	CcSEcCtD
Melatonin—Asthenia—Mycophenolate mofetil—psoriasis	9.43e-05	0.000488	CcSEcCtD
Melatonin—Hypertension—Prednisone—psoriasis	9.42e-05	0.000487	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Dexamethasone—psoriasis	9.32e-05	0.000482	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Betamethasone—psoriasis	9.32e-05	0.000482	CcSEcCtD
Melatonin—Pruritus—Mycophenolate mofetil—psoriasis	9.3e-05	0.000481	CcSEcCtD
Melatonin—Arthralgia—Prednisone—psoriasis	9.29e-05	0.000481	CcSEcCtD
Melatonin—Anxiety—Prednisone—psoriasis	9.26e-05	0.000479	CcSEcCtD
Melatonin—Insomnia—Dexamethasone—psoriasis	9.25e-05	0.000479	CcSEcCtD
Melatonin—Insomnia—Betamethasone—psoriasis	9.25e-05	0.000479	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	9.23e-05	0.000477	CcSEcCtD
Melatonin—Paraesthesia—Dexamethasone—psoriasis	9.18e-05	0.000475	CcSEcCtD
Melatonin—Paraesthesia—Betamethasone—psoriasis	9.18e-05	0.000475	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—psoriasis	9.18e-05	0.000475	CcSEcCtD
Melatonin—Erythema—Methotrexate—psoriasis	9.12e-05	0.000472	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—psoriasis	9.12e-05	0.000472	CcSEcCtD
Melatonin—Hypersensitivity—Prednisolone—psoriasis	9.03e-05	0.000467	CcSEcCtD
Melatonin—Dyspepsia—Dexamethasone—psoriasis	9e-05	0.000466	CcSEcCtD
Melatonin—Dyspepsia—Betamethasone—psoriasis	9e-05	0.000466	CcSEcCtD
Melatonin—Dizziness—Cyclosporine—psoriasis	8.91e-05	0.000461	CcSEcCtD
Melatonin—Infection—Prednisone—psoriasis	8.85e-05	0.000458	CcSEcCtD
Melatonin—Gastrointestinal disorder—Betamethasone—psoriasis	8.83e-05	0.000457	CcSEcCtD
Melatonin—Gastrointestinal disorder—Dexamethasone—psoriasis	8.83e-05	0.000457	CcSEcCtD
Melatonin—Back pain—Methotrexate—psoriasis	8.82e-05	0.000456	CcSEcCtD
Melatonin—Hypersensitivity—Hydrocortisone—psoriasis	8.82e-05	0.000456	CcSEcCtD
Melatonin—Fatigue—Betamethasone—psoriasis	8.82e-05	0.000456	CcSEcCtD
Melatonin—Fatigue—Dexamethasone—psoriasis	8.82e-05	0.000456	CcSEcCtD
Melatonin—Shock—Prednisone—psoriasis	8.76e-05	0.000453	CcSEcCtD
Melatonin—Pain—Betamethasone—psoriasis	8.75e-05	0.000452	CcSEcCtD
Melatonin—Pain—Dexamethasone—psoriasis	8.75e-05	0.000452	CcSEcCtD
Melatonin—Nervous system disorder—Prednisone—psoriasis	8.73e-05	0.000452	CcSEcCtD
Melatonin—Dizziness—Mycophenolate mofetil—psoriasis	8.69e-05	0.00045	CcSEcCtD
Melatonin—Skin disorder—Prednisone—psoriasis	8.65e-05	0.000448	CcSEcCtD
Melatonin—Vision blurred—Methotrexate—psoriasis	8.6e-05	0.000445	CcSEcCtD
Melatonin—Asthenia—Hydrocortisone—psoriasis	8.59e-05	0.000444	CcSEcCtD
Melatonin—Vomiting—Cyclosporine—psoriasis	8.56e-05	0.000443	CcSEcCtD
Melatonin—Rash—Cyclosporine—psoriasis	8.49e-05	0.000439	CcSEcCtD
Melatonin—Dermatitis—Cyclosporine—psoriasis	8.48e-05	0.000439	CcSEcCtD
Melatonin—Pruritus—Hydrocortisone—psoriasis	8.47e-05	0.000438	CcSEcCtD
Melatonin—Headache—Cyclosporine—psoriasis	8.44e-05	0.000437	CcSEcCtD
Melatonin—Gastrointestinal pain—Betamethasone—psoriasis	8.36e-05	0.000433	CcSEcCtD
Melatonin—Gastrointestinal pain—Dexamethasone—psoriasis	8.36e-05	0.000433	CcSEcCtD
Melatonin—Vomiting—Mycophenolate mofetil—psoriasis	8.35e-05	0.000432	CcSEcCtD
Melatonin—Hypersensitivity—Triamcinolone—psoriasis	8.3e-05	0.00043	CcSEcCtD
Melatonin—Rash—Mycophenolate mofetil—psoriasis	8.28e-05	0.000429	CcSEcCtD
Melatonin—Dermatitis—Mycophenolate mofetil—psoriasis	8.28e-05	0.000428	CcSEcCtD
Melatonin—Headache—Mycophenolate mofetil—psoriasis	8.23e-05	0.000426	CcSEcCtD
Melatonin—Vertigo—Methotrexate—psoriasis	8.19e-05	0.000424	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—psoriasis	8.16e-05	0.000422	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Prednisone—psoriasis	8.11e-05	0.00042	CcSEcCtD
Melatonin—Dizziness—Prednisolone—psoriasis	8.1e-05	0.000419	CcSEcCtD
Melatonin—Asthenia—Triamcinolone—psoriasis	8.09e-05	0.000418	CcSEcCtD
Melatonin—Abdominal pain—Dexamethasone—psoriasis	8.08e-05	0.000418	CcSEcCtD
Melatonin—Abdominal pain—Betamethasone—psoriasis	8.08e-05	0.000418	CcSEcCtD
Melatonin—Insomnia—Prednisone—psoriasis	8.06e-05	0.000417	CcSEcCtD
Melatonin—Nausea—Cyclosporine—psoriasis	8e-05	0.000414	CcSEcCtD
Melatonin—Paraesthesia—Prednisone—psoriasis	8e-05	0.000414	CcSEcCtD
Melatonin—Pruritus—Triamcinolone—psoriasis	7.97e-05	0.000413	CcSEcCtD
Melatonin—Dizziness—Hydrocortisone—psoriasis	7.92e-05	0.00041	CcSEcCtD
Melatonin—Dyspepsia—Prednisone—psoriasis	7.84e-05	0.000406	CcSEcCtD
Melatonin—Nausea—Mycophenolate mofetil—psoriasis	7.8e-05	0.000404	CcSEcCtD
Melatonin—Chest pain—Methotrexate—psoriasis	7.76e-05	0.000402	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—psoriasis	7.76e-05	0.000402	CcSEcCtD
Melatonin—Rash—Prednisolone—psoriasis	7.73e-05	0.0004	CcSEcCtD
Melatonin—Dermatitis—Prednisolone—psoriasis	7.72e-05	0.000399	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	7.71e-05	0.000399	CcSEcCtD
Melatonin—Fatigue—Prednisone—psoriasis	7.68e-05	0.000397	CcSEcCtD
Melatonin—Headache—Prednisolone—psoriasis	7.68e-05	0.000397	CcSEcCtD
Melatonin—Vomiting—Hydrocortisone—psoriasis	7.61e-05	0.000394	CcSEcCtD
Melatonin—Rash—Hydrocortisone—psoriasis	7.55e-05	0.00039	CcSEcCtD
Melatonin—Dermatitis—Hydrocortisone—psoriasis	7.54e-05	0.00039	CcSEcCtD
Melatonin—Headache—Hydrocortisone—psoriasis	7.5e-05	0.000388	CcSEcCtD
Melatonin—Dizziness—Triamcinolone—psoriasis	7.45e-05	0.000386	CcSEcCtD
Melatonin—Infection—Methotrexate—psoriasis	7.39e-05	0.000383	CcSEcCtD
Melatonin—Asthenia—Dexamethasone—psoriasis	7.34e-05	0.00038	CcSEcCtD
Melatonin—Asthenia—Betamethasone—psoriasis	7.34e-05	0.00038	CcSEcCtD
Melatonin—Nervous system disorder—Methotrexate—psoriasis	7.3e-05	0.000378	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—psoriasis	7.29e-05	0.000377	CcSEcCtD
Melatonin—Gastrointestinal pain—Prednisone—psoriasis	7.28e-05	0.000377	CcSEcCtD
Melatonin—Nausea—Prednisolone—psoriasis	7.28e-05	0.000377	CcSEcCtD
Melatonin—Pruritus—Betamethasone—psoriasis	7.24e-05	0.000374	CcSEcCtD
Melatonin—Pruritus—Dexamethasone—psoriasis	7.24e-05	0.000374	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—psoriasis	7.23e-05	0.000374	CcSEcCtD
Melatonin—Vomiting—Triamcinolone—psoriasis	7.17e-05	0.000371	CcSEcCtD
Melatonin—Nausea—Hydrocortisone—psoriasis	7.11e-05	0.000368	CcSEcCtD
Melatonin—Rash—Triamcinolone—psoriasis	7.11e-05	0.000368	CcSEcCtD
Melatonin—Dermatitis—Triamcinolone—psoriasis	7.1e-05	0.000367	CcSEcCtD
Melatonin—Headache—Triamcinolone—psoriasis	7.06e-05	0.000365	CcSEcCtD
Melatonin—Abdominal pain—Prednisone—psoriasis	7.04e-05	0.000364	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methotrexate—psoriasis	6.78e-05	0.000351	CcSEcCtD
Melatonin—Dizziness—Dexamethasone—psoriasis	6.76e-05	0.00035	CcSEcCtD
Melatonin—Dizziness—Betamethasone—psoriasis	6.76e-05	0.00035	CcSEcCtD
Melatonin—Insomnia—Methotrexate—psoriasis	6.73e-05	0.000348	CcSEcCtD
Melatonin—Nausea—Triamcinolone—psoriasis	6.69e-05	0.000346	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—psoriasis	6.68e-05	0.000346	CcSEcCtD
Melatonin—Somnolence—Methotrexate—psoriasis	6.62e-05	0.000342	CcSEcCtD
Melatonin—Hypersensitivity—Prednisone—psoriasis	6.56e-05	0.00034	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—psoriasis	6.55e-05	0.000339	CcSEcCtD
Melatonin—Vomiting—Dexamethasone—psoriasis	6.5e-05	0.000336	CcSEcCtD
Melatonin—Vomiting—Betamethasone—psoriasis	6.5e-05	0.000336	CcSEcCtD
Melatonin—Rash—Betamethasone—psoriasis	6.45e-05	0.000334	CcSEcCtD
Melatonin—Rash—Dexamethasone—psoriasis	6.45e-05	0.000334	CcSEcCtD
Melatonin—Dermatitis—Dexamethasone—psoriasis	6.44e-05	0.000333	CcSEcCtD
Melatonin—Dermatitis—Betamethasone—psoriasis	6.44e-05	0.000333	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—psoriasis	6.43e-05	0.000332	CcSEcCtD
Melatonin—Fatigue—Methotrexate—psoriasis	6.42e-05	0.000332	CcSEcCtD
Melatonin—Headache—Betamethasone—psoriasis	6.41e-05	0.000331	CcSEcCtD
Melatonin—Headache—Dexamethasone—psoriasis	6.41e-05	0.000331	CcSEcCtD
Melatonin—Asthenia—Prednisone—psoriasis	6.39e-05	0.000331	CcSEcCtD
Melatonin—Pain—Methotrexate—psoriasis	6.37e-05	0.000329	CcSEcCtD
Melatonin—Pruritus—Prednisone—psoriasis	6.3e-05	0.000326	CcSEcCtD
Melatonin—Gastrointestinal pain—Methotrexate—psoriasis	6.09e-05	0.000315	CcSEcCtD
Melatonin—Nausea—Betamethasone—psoriasis	6.07e-05	0.000314	CcSEcCtD
Melatonin—Nausea—Dexamethasone—psoriasis	6.07e-05	0.000314	CcSEcCtD
Melatonin—Dizziness—Prednisone—psoriasis	5.89e-05	0.000305	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—psoriasis	5.88e-05	0.000304	CcSEcCtD
Melatonin—Vomiting—Prednisone—psoriasis	5.66e-05	0.000293	CcSEcCtD
Melatonin—Rash—Prednisone—psoriasis	5.62e-05	0.000291	CcSEcCtD
Melatonin—Dermatitis—Prednisone—psoriasis	5.61e-05	0.00029	CcSEcCtD
Melatonin—Headache—Prednisone—psoriasis	5.58e-05	0.000289	CcSEcCtD
Melatonin—Hypersensitivity—Methotrexate—psoriasis	5.48e-05	0.000284	CcSEcCtD
Melatonin—Asthenia—Methotrexate—psoriasis	5.34e-05	0.000276	CcSEcCtD
Melatonin—Nausea—Prednisone—psoriasis	5.29e-05	0.000274	CcSEcCtD
Melatonin—Pruritus—Methotrexate—psoriasis	5.27e-05	0.000272	CcSEcCtD
Melatonin—Dizziness—Methotrexate—psoriasis	4.92e-05	0.000255	CcSEcCtD
Melatonin—Vomiting—Methotrexate—psoriasis	4.73e-05	0.000245	CcSEcCtD
Melatonin—Rash—Methotrexate—psoriasis	4.69e-05	0.000243	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—psoriasis	4.69e-05	0.000243	CcSEcCtD
Melatonin—Headache—Methotrexate—psoriasis	4.66e-05	0.000241	CcSEcCtD
Melatonin—Nausea—Methotrexate—psoriasis	4.42e-05	0.000229	CcSEcCtD
Melatonin—CALM2—Adaptive Immune System—HLA-A—psoriasis	1.65e-05	0.000134	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HLA-A—psoriasis	1.65e-05	0.000134	CbGpPWpGaD
Melatonin—CALM2—Signaling by ERBB2—IL6—psoriasis	1.65e-05	0.000134	CbGpPWpGaD
Melatonin—CALM1—Signaling by ERBB2—IL6—psoriasis	1.65e-05	0.000134	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—CRP—psoriasis	1.64e-05	0.000134	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—CRP—psoriasis	1.64e-05	0.000134	CbGpPWpGaD
Melatonin—CALM1—DAP12 signaling—IL6—psoriasis	1.64e-05	0.000133	CbGpPWpGaD
Melatonin—CALM2—DAP12 signaling—IL6—psoriasis	1.64e-05	0.000133	CbGpPWpGaD
Melatonin—CALM3—DAP12 interactions—IL6—psoriasis	1.59e-05	0.00013	CbGpPWpGaD
Melatonin—CALM3—Signaling by FGFR in disease—IL6—psoriasis	1.59e-05	0.00013	CbGpPWpGaD
Melatonin—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	1.59e-05	0.00013	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.59e-05	0.00013	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR—IL6—psoriasis	1.58e-05	0.000129	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-E—psoriasis	1.57e-05	0.000128	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR in Cancer—IL6—psoriasis	1.57e-05	0.000128	CbGpPWpGaD
Melatonin—CALM3—Metabolism—CARM1—psoriasis	1.56e-05	0.000127	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HLA-DRB1—psoriasis	1.56e-05	0.000127	CbGpPWpGaD
Melatonin—CALM3—Signaling by PDGF—IL6—psoriasis	1.56e-05	0.000127	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—STAT3—psoriasis	1.55e-05	0.000127	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—NFKBIA—psoriasis	1.55e-05	0.000126	CbGpPWpGaD
Melatonin—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	1.54e-05	0.000126	CbGpPWpGaD
Melatonin—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	1.54e-05	0.000126	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR in disease—IL6—psoriasis	1.54e-05	0.000126	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—IL6—psoriasis	1.54e-05	0.000126	CbGpPWpGaD
Melatonin—CALM1—DAP12 interactions—IL6—psoriasis	1.54e-05	0.000126	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR in disease—IL6—psoriasis	1.54e-05	0.000126	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—CAT—psoriasis	1.54e-05	0.000125	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCL20—psoriasis	1.54e-05	0.000125	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR—IL6—psoriasis	1.53e-05	0.000124	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR—IL6—psoriasis	1.53e-05	0.000124	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-E—psoriasis	1.52e-05	0.000124	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-E—psoriasis	1.52e-05	0.000124	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR in Cancer—IL6—psoriasis	1.51e-05	0.000123	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR in Cancer—IL6—psoriasis	1.51e-05	0.000123	CbGpPWpGaD
Melatonin—CALM2—Metabolism—CARM1—psoriasis	1.51e-05	0.000123	CbGpPWpGaD
Melatonin—CALM1—Metabolism—CARM1—psoriasis	1.51e-05	0.000123	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HLA-DRB1—psoriasis	1.51e-05	0.000123	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HLA-DRB1—psoriasis	1.51e-05	0.000123	CbGpPWpGaD
Melatonin—CALM2—Signaling by PDGF—IL6—psoriasis	1.51e-05	0.000123	CbGpPWpGaD
Melatonin—CALM1—Signaling by PDGF—IL6—psoriasis	1.51e-05	0.000123	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—STAT3—psoriasis	1.5e-05	0.000122	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—STAT3—psoriasis	1.5e-05	0.000122	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—ICAM1—psoriasis	1.5e-05	0.000122	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—NFKBIA—psoriasis	1.5e-05	0.000122	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—NFKBIA—psoriasis	1.5e-05	0.000122	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCL20—psoriasis	1.49e-05	0.000121	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCL20—psoriasis	1.49e-05	0.000121	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—NFKBIA—psoriasis	1.48e-05	0.000121	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—CARM1—psoriasis	1.48e-05	0.000121	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—CAT—psoriasis	1.48e-05	0.000121	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—ICAM1—psoriasis	1.45e-05	0.000118	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—ICAM1—psoriasis	1.45e-05	0.000118	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—NFKBIA—psoriasis	1.44e-05	0.000117	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—NFKBIA—psoriasis	1.44e-05	0.000117	CbGpPWpGaD
Melatonin—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	1.41e-05	0.000115	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.39e-05	0.000113	CbGpPWpGaD
Melatonin—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	1.37e-05	0.000111	CbGpPWpGaD
Melatonin—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	1.37e-05	0.000111	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—TP53—psoriasis	1.36e-05	0.000111	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—TP53—psoriasis	1.36e-05	0.000111	CbGpPWpGaD
Melatonin—CALM3—Immune System—SOCS1—psoriasis	1.31e-05	0.000107	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.3e-05	0.000106	CbGpPWpGaD
Melatonin—CALM2—Immune System—SOCS1—psoriasis	1.27e-05	0.000103	CbGpPWpGaD
Melatonin—CALM1—Immune System—SOCS1—psoriasis	1.27e-05	0.000103	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—TYK2—psoriasis	1.27e-05	0.000103	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—IL6—psoriasis	1.24e-05	0.000101	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—IL6—psoriasis	1.24e-05	0.000101	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—TYK2—psoriasis	1.22e-05	9.98e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—TYK2—psoriasis	1.22e-05	9.98e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CARM1—psoriasis	1.21e-05	9.89e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SOCS1—psoriasis	1.21e-05	9.88e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—PPARG—psoriasis	1.2e-05	9.76e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—APOE—psoriasis	1.2e-05	9.74e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.19e-05	9.67e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CD8A—psoriasis	1.16e-05	9.46e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—APOE—psoriasis	1.15e-05	9.38e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—CD4—psoriasis	1.15e-05	9.33e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.13e-05	9.24e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD8A—psoriasis	1.12e-05	9.15e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD8A—psoriasis	1.12e-05	9.15e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-B—psoriasis	1.12e-05	9.1e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—CD4—psoriasis	1.11e-05	9.02e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—CD4—psoriasis	1.11e-05	9.02e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CARM1—psoriasis	1.11e-05	9.02e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—CD4—psoriasis	1.1e-05	8.96e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—IL6—psoriasis	1.09e-05	8.84e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-B—psoriasis	1.08e-05	8.8e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-B—psoriasis	1.08e-05	8.8e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CD4—psoriasis	1.06e-05	8.66e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CD4—psoriasis	1.06e-05	8.66e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—IL6—psoriasis	1.05e-05	8.56e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—IL6—psoriasis	1.05e-05	8.56e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PPARG—psoriasis	1.04e-05	8.48e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-A—psoriasis	1.04e-05	8.43e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.03e-05	8.43e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—JUN—psoriasis	1.02e-05	8.35e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.01e-05	8.27e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PPARG—psoriasis	1e-05	8.17e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-A—psoriasis	1e-05	8.16e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-A—psoriasis	1e-05	8.16e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—VEGFA—psoriasis	9.95e-06	8.1e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—JUN—psoriasis	9.91e-06	8.08e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—JUN—psoriasis	9.91e-06	8.08e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CRP—psoriasis	9.87e-06	8.04e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—NFKB1—psoriasis	9.87e-06	8.04e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—VEGFA—psoriasis	9.62e-06	7.84e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—VEGFA—psoriasis	9.62e-06	7.84e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—CAT—psoriasis	9.62e-06	7.83e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—HLA-A—psoriasis	9.56e-06	7.78e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CRP—psoriasis	9.55e-06	7.78e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CRP—psoriasis	9.55e-06	7.78e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—NFKB1—psoriasis	9.54e-06	7.77e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—NFKB1—psoriasis	9.54e-06	7.77e-05	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—NFKB1—psoriasis	9.47e-06	7.72e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CARM1—psoriasis	9.46e-06	7.7e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-DRB1—psoriasis	9.46e-06	7.7e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—CAT—psoriasis	9.3e-06	7.58e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—CAT—psoriasis	9.3e-06	7.58e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—HLA-A—psoriasis	9.24e-06	7.53e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—HLA-A—psoriasis	9.24e-06	7.53e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—NFKB1—psoriasis	9.16e-06	7.46e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—NFKB1—psoriasis	9.16e-06	7.46e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-DRB1—psoriasis	9.15e-06	7.45e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-DRB1—psoriasis	9.15e-06	7.45e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—CAT—psoriasis	9.12e-06	7.43e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—ICAM1—psoriasis	9.08e-06	7.39e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—NFKBIA—psoriasis	9e-06	7.33e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—LEP—psoriasis	8.95e-06	7.29e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—APOE—psoriasis	8.95e-06	7.29e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—APOE—psoriasis	8.92e-06	7.27e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.84e-06	7.2e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—ICAM1—psoriasis	8.78e-06	7.15e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—ICAM1—psoriasis	8.78e-06	7.15e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NFKBIA—psoriasis	8.71e-06	7.09e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NFKBIA—psoriasis	8.71e-06	7.09e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—APOE—psoriasis	8.63e-06	7.03e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—APOE—psoriasis	8.63e-06	7.03e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SOCS1—psoriasis	8.47e-06	6.9e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NFKBIA—psoriasis	8.34e-06	6.79e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NOS2—psoriasis	8.31e-06	6.77e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SOCS1—psoriasis	8.19e-06	6.67e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SOCS1—psoriasis	8.19e-06	6.67e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—TYK2—psoriasis	8.07e-06	6.57e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NOS2—psoriasis	8.04e-06	6.55e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NOS2—psoriasis	8.04e-06	6.55e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—TYK2—psoriasis	7.81e-06	6.36e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—TYK2—psoriasis	7.81e-06	6.36e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TP53—psoriasis	7.51e-06	6.12e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—APOE—psoriasis	7.47e-06	6.09e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CAT—psoriasis	7.47e-06	6.08e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—TYK2—psoriasis	7.37e-06	6.01e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TP53—psoriasis	7.27e-06	5.92e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TP53—psoriasis	7.27e-06	5.92e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—APOE—psoriasis	7.23e-06	5.89e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—APOE—psoriasis	7.23e-06	5.89e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—TYK2—psoriasis	7.13e-06	5.81e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—TYK2—psoriasis	7.13e-06	5.81e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—APOE—psoriasis	7.09e-06	5.77e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—CXCL8—psoriasis	7.03e-06	5.72e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IFNG—psoriasis	6.91e-06	5.62e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TYK2—psoriasis	6.83e-06	5.56e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—TYK2—psoriasis	6.81e-06	5.55e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CAT—psoriasis	6.81e-06	5.54e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—CXCL8—psoriasis	6.8e-06	5.54e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—CXCL8—psoriasis	6.8e-06	5.54e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IFNG—psoriasis	6.68e-06	5.44e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IFNG—psoriasis	6.68e-06	5.44e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CD4—psoriasis	6.67e-06	5.43e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—TYK2—psoriasis	6.59e-06	5.36e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—TYK2—psoriasis	6.59e-06	5.36e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PPARG—psoriasis	6.51e-06	5.3e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD4—psoriasis	6.45e-06	5.26e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD4—psoriasis	6.45e-06	5.26e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PPARG—psoriasis	6.3e-06	5.13e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PPARG—psoriasis	6.3e-06	5.13e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—LEP—psoriasis	6.25e-06	5.09e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—APOE—psoriasis	6.25e-06	5.09e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—IL6—psoriasis	6.19e-06	5.04e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PPARG—psoriasis	6.17e-06	5.03e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—CD4—psoriasis	6.16e-06	5.02e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—LEP—psoriasis	6.04e-06	4.92e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—APOE—psoriasis	6.04e-06	4.92e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—APOE—psoriasis	6.04e-06	4.92e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—LEP—psoriasis	6.04e-06	4.92e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—IL6—psoriasis	5.99e-06	4.88e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—IL6—psoriasis	5.99e-06	4.88e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—JUN—psoriasis	5.97e-06	4.86e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CD4—psoriasis	5.96e-06	4.85e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CD4—psoriasis	5.96e-06	4.85e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CXCL8—psoriasis	5.95e-06	4.84e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NFKBIA—psoriasis	5.82e-06	4.74e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CAT—psoriasis	5.82e-06	4.74e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—APOE—psoriasis	5.8e-06	4.73e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—JUN—psoriasis	5.77e-06	4.7e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—JUN—psoriasis	5.77e-06	4.7e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—NFKB1—psoriasis	5.75e-06	4.68e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NFKBIA—psoriasis	5.63e-06	4.59e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NFKBIA—psoriasis	5.63e-06	4.59e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NFKB1—psoriasis	5.56e-06	4.53e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NFKB1—psoriasis	5.56e-06	4.53e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—JUN—psoriasis	5.53e-06	4.5e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NFKB1—psoriasis	5.32e-06	4.33e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—APOE—psoriasis	5.29e-06	4.31e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—STAT3—psoriasis	5.16e-06	4.21e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PPARG—psoriasis	5.05e-06	4.12e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—STAT3—psoriasis	5e-06	4.07e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—STAT3—psoriasis	5e-06	4.07e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—psoriasis	4.83e-06	3.93e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STAT3—psoriasis	4.78e-06	3.9e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TYK2—psoriasis	4.77e-06	3.88e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—STAT3—psoriasis	4.77e-06	3.88e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TYK2—psoriasis	4.61e-06	3.76e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TYK2—psoriasis	4.61e-06	3.76e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—STAT3—psoriasis	4.61e-06	3.76e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—STAT3—psoriasis	4.61e-06	3.76e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PPARG—psoriasis	4.61e-06	3.75e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—APOE—psoriasis	4.52e-06	3.68e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCL8—psoriasis	4.15e-06	3.38e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCL8—psoriasis	4.02e-06	3.27e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCL8—psoriasis	4.02e-06	3.27e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—psoriasis	3.95e-06	3.22e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPARG—psoriasis	3.94e-06	3.21e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—JUN—psoriasis	3.86e-06	3.14e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—psoriasis	3.82e-06	3.11e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—psoriasis	3.82e-06	3.11e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—JUN—psoriasis	3.73e-06	3.04e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—JUN—psoriasis	3.73e-06	3.04e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NFKB1—psoriasis	3.72e-06	3.03e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—psoriasis	3.65e-06	2.97e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—psoriasis	3.61e-06	2.94e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NFKB1—psoriasis	3.59e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NFKB1—psoriasis	3.59e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—psoriasis	3.49e-06	2.84e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—psoriasis	3.49e-06	2.84e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—psoriasis	3.37e-06	2.75e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—psoriasis	3.34e-06	2.72e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STAT3—psoriasis	3.34e-06	2.72e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—psoriasis	3.33e-06	2.71e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—psoriasis	3.26e-06	2.66e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—psoriasis	3.26e-06	2.66e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STAT3—psoriasis	3.23e-06	2.63e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STAT3—psoriasis	3.23e-06	2.63e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—psoriasis	3.22e-06	2.62e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—psoriasis	3.22e-06	2.62e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—psoriasis	2.55e-06	2.08e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—psoriasis	2.46e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—psoriasis	2.46e-06	2.01e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—psoriasis	2.33e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—psoriasis	2.26e-06	1.84e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—psoriasis	2.26e-06	1.84e-05	CbGpPWpGaD
